AIM2 and COVID-19: Importantly, stimulation of AIM2 responses in PBMCs obtained from both non-fibrotic (Figure 3E) or fibrotic (Figure 3F) PC patients, did not induce increases of IL-1β, a cytokine which is elevated in COVID-19 and correlates with disease symptoms (1).